Due to the limitations of whole exome sequencing and the study design we were unable to assess the prevalence of the intermediate ATXN2 CAG expansion, which has also been associated with ALS risk, in our cohort [40]. Here, ATXN2 is linked to amyotrophic lateral sclerosis.